Genpact (G): Evaluating Valuation as Shares Stabilize After Recent Underperformance

Simply Wall St.

Nov 01

Genpact (G) shares have edged higher today, brushing off a choppy trading week. Investors are watching as the company’s recent returns have lagged the market, which has raised questions around its ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2580841571"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2580841571\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2580841571?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/8032000-choice1-main-header/1585186551780","is_english":true,"pubTime":"2025-11-01 00:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2580841571","market":"sg","top_or_hot":-1,"title":"Genpact (G): Evaluating Valuation as Shares Stabilize After Recent Underperformance","media":"Simply Wall St.","content":"<div>\n<p>Genpact (G) shares have edged higher today, brushing off a choppy trading week. Investors are watching as the company’s recent returns have lagged the market, which has raised questions around its ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/commercial-services/nyse-g/genpact/news/genpact-g-evaluating-valuation-as-shares-stabilize-after-rec\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genpact (G): Evaluating Valuation as Shares Stabilize After Recent Underperformance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenpact (G): Evaluating Valuation as Shares Stabilize After Recent Underperformance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-11-01 00:38 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/commercial-services/nyse-g/genpact/news/genpact-g-evaluating-valuation-as-shares-stabilize-after-rec><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Genpact (G) shares have edged higher today, brushing off a choppy trading week. Investors are watching as the company’s recent returns have lagged the market, which has raised questions around its ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/commercial-services/nyse-g/genpact/news/genpact-g-evaluating-valuation-as-shares-stabilize-after-rec\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"G","symbol_name":"简伯特","start_time":0,"source_url":"https://simplywall.st/stocks/us/commercial-services/nyse-g/genpact/news/genpact-g-evaluating-valuation-as-shares-stabilize-after-rec","article_id":"2580841571","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/8032000-choice1-main-header/1585186551780"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/commercial-services/nyse-g/genpact/news/genpact-g-evaluating-valuation-as-shares-stabilize-after-rec","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2580841571","pubTimestamp":1761928718,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Genpact (G) shares have edged higher today, brushing off a choppy trading week. Investors are watching as the company’s recent returns have lagged the market, which has raised questions around its current valuation and future prospects.\nSee our latest analysis for Genpact.\nGenpact’s share price has slipped 9% over the past month, reflecting some uncertainty after a weaker week and a longer stretch of underperformance. Even so, its one-year total shareholder return stands at 1.35%, and...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"G":"简伯特"},"translate_title":"简柏特(G)：随着股价在近期表现不佳后企稳，评估估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"G":1.5},"content_text":"Genpact (G) shares have edged higher today, brushing off a choppy trading week. Investors are watching as the company’s recent returns have lagged the market, which has raised questions around its current valuation and future prospects.\nSee our latest analysis for Genpact. Genpact’s share price has slipped 9% over the past month, reflecting some uncertainty after a weaker week and a longer stretch of underperformance. Even so, its one-year total shareholder return stands at 1.35%, and five-year total returns are still in positive territory. This suggests that momentum may be stabilizing after a challenging period. If you’re interested in what else investors are watching, it’s a great moment to broaden your search and discover fast growing stocks with high insider ownership With shares trading well below analysts’ price targets while recent growth trends remain muted, the question remains: is Genpact now trading at a bargain, or is the market fairly reflecting its future growth potential? AdvertisementMost Popular Narrative: 24.2% Undervalued With Genpact’s fair value pegged at $50.30 versus a last close of $38.12, the narrative points to substantial upside ahead. This gap could reinforce investor optimism if the company meets future expectations.   Accelerated client adoption of Genpact's Advanced Technology Solutions, particularly in data and AI, should drive higher growth and improved margins. These offerings deliver over twice the revenue per headcount compared to legacy services and are expanding at more than twice the company's overall rate, pointing toward robust long-term revenue and margin expansion.\n    Read the complete narrative. Want to know what’s fueling this bullish view? There are bold growth assumptions behind the fair value, driven by future revenue acceleration and a dramatic shift in profit margins. Curious how those projections stack up? Dive in to see what powers this standout valuation. Result: Fair Value of $50.30 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, slowing growth in legacy services and ongoing macroeconomic uncertainty could challenge Genpact's pace of transformation and put pressure on future earnings momentum. Find out about the key risks to this Genpact narrative.  Build Your Own Genpact Narrative If you see things differently or want to dig into the numbers yourself, it’s easy to craft your own view of Genpact in just minutes. Do it your way A great starting point for your Genpact research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision. Looking for More Smart Investment Opportunities? If you want to stay ahead of the curve, now's your chance to uncover fresh ideas that could transform your portfolio and unlock untapped growth potential.  Spot income potential with impressive yields by analyzing these 24 dividend stocks with yields > 3%, which consistently deliver over 3% payouts to shareholders. Tap into emerging healthcare trends by reviewing these 34 healthcare AI stocks, making waves with next-generation medical innovation and artificial intelligence breakthroughs. Step ahead of Wall Street and assess value picks among these 832 undervalued stocks based on cash flows, fueled by strong cash flows and favorable pricing signals.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}